ALDH1A1 and breast carcinoma: For example, silencing of the ALDH1A1 gene in human breast cancer cells increases their sensitivity to paclitaxel by triggering the production of ROS, and similar results are obtained with other anticancer agents such as doxorubicin, sorafenib, and staurosporine.28